This case study highlights how we engineered a scalable, patient-centric pharmacy solution for Eli Lilly’s immunology pilot, validating new high-touch fulfillment and payer coordination models.
LAUNCH TIMELINE
12-week delivery
PARTNERSHIP EXPANSION
EMR modernization
Truepill (now operating under the Fuze Health umbrella) provides an API-first platform that enables pharmaceutical brands, telehealth providers, and health insurers to launch and scale national pharmacy experiences. By combining a digital healthcare platform with a physical network of high-tech fulfillment centers, the company streamlines the test-to-treat process for millions of patients.
Our partnership began when Truepill engaged the Codal team to build a new platform that would allow pharmaceutical companies to connect with buyers, educate them on certain drugs, then sell and deliver the products directly. The goal was to remove distributors, logistics services, and other middlemen from the process.
The new platform’s impact was quickly evident. Pharma companies were able to better communicate with their customers, offer more competitive pricing, and speed up delivery times. Our team delivered the new platform quickly and seamlessly, meeting tight timelines in areas where internal teams had previously struggled.
Several years later and following a major internal reorganization, TruePill evolved into Fuze Health, a healthtech system that also includes Alto Health (women’s health), LetsGetChecked (at-home diagnostics), and TruePill (general pharmacy). Although the leadership and entity structure had changed, Fuze Health re-engaged with Codal when additional requirements emerged.
The new leaders were briefed on our capabilities and previous successful delivery, and trusted us to execute the next phase of their digital roadmap.
During strategic planning discussions with Fuze Health, the organization identified opportunities to expand into specialty pharmacy services while modernizing key clinical workflows. A new partnership with Eli Lilly created an opportunity to launch a differentiated immunology program, requiring new patient engagement capabilities, payer coordination workflows, specialty pharmacy integrations, and enhanced operational visibility, all within an aggressive timeline.
The immunology pilot project launched as a result of the visioning workshop. Fuze Health wanted to expand into the specialty drug space, and its new partnership with Eli Lilly was the right opportunity. Beyond the immediate pilot requirements, the initiative established a repeatable framework for launching future specialty therapy programs while improving operational efficiency across patient onboarding, insurance coordination, and fulfillment workflows.
With Codal as the consultant and technical lead, Fuze Health and Eli Lilly sought to co-develop and validate a scalable, patient-centric pharmacy solution tailored to complex specialty immunology therapies. The initiative served as the foundational step to provide partner pharmacies with a seamless, high-touch experience across fulfillment, payer coordination, and patient engagement.
To meet market demand for these new therapies, the project was set with a high-stakes, pre-defined timeline of 10 to 12 weeks. Our team immediately began leading a mini discovery process to refine the exact product requirements. Through a series of working sessions, we translated the existing high-level business requirements into a granular technical PRD (product requirement document). With that blueprint in place, our team was able to navigate the aggressive timeline with a clear roadmap.
We provided end-to-end support across the full tech stack: backend (Node.js), frontend (React.js), QA (Playwright), and CMS (Contentful). Other key features and functionalities include:
The immunology pilot project successfully transformed a high-touch, manual process into a flexible, scalable eCommerce ecosystem. We delivered all requirements within the strict 12-week deadline.
The impact was immediately felt across the patient and provider journey. The new appeal status tracker gives patients real-time visibility into the insurance process, reducing the anxiety and administrative friction often associated with high-cost specialty drugs. The internal drug savings API lowers the barrier to treatment for new-to-market therapies through automatically served virtual cards. And platform enhancements provide greater flexibility for launching future specialty therapy programs while improving patient communication, payer coordination, and operational efficiency.
The success of the engagement extended beyond the code delivered. In addition to building and shipping features, we provided operational mentorship throughout the process and helped Fuze Health mature their internal engineering culture. We also optimized their Jira environment and implemented rigorous code review and status reporting workflows.
Because documentation for the existing system was light and knowledge of the various APIs was dispersed across the organization, our developers worked directly with members of their engineering team in real time to bridge those gaps and compile the technical requirements needed for integration.
Fuze Health recognized our collaborative project management style, which prioritizes transparency and careful documentation. The pilot project concluded with our team teaching their internal teams how to replicate the same organizational efficiency.
Building on the momentum achieved, our partnership transitioned into a third phase: modernizing Fuze Health’s electronic medical record system (EMR).
This project focused on a high-impact community and support program in partnership with UnitedHealthcare (UHC). The system was designed to identify and support patients immediately following an ER discharge, automatically connecting them with clinicians for critical behavioral health programs and suicide prevention services.
The initiative focused on enhancing and modernizing Fuze Health’s EMR capabilities to better support clinical outreach, behavioral health programs, care coordination, and future program expansion. The platform was designed to improve configurability, streamline clinical workflows, and provide a stronger foundation for future patient support initiatives.
With a primary target of 25% of contacted patients completing a clinical assessment, the initiative represents the next step in our shared mission to create a more connected, responsible, and patient-centric healthcare experience.
Together, the Immunology Pilot and EMR modernization efforts demonstrate Codal’s ability to support Fuze Health across both patient-facing and operational platforms. From launching specialty pharmacy programs under aggressive timelines to improving the systems that power clinical care delivery, the partnership continues to focus on expanding patient access, improving outcomes, and building scalable healthcare experiences.
If this case study sparked ideas, let’s talk. From strategy and experience design to unified commerce and product engineering, Codal helps ambitious brands turn vision into reality.
